Send me a link:

*Text messaging rates may apply.

 Dow Up 0.02% Nasdaq Down 0.07%

Neurocrine Biosciences Inc. (NBIX)

-NasdaqGS
13.56 Down 0.15(1.09%) 10:08AM EDT - Nasdaq Real Time Price
Prev Close:13.71
Open:13.72
Bid:13.64 x 700
Ask:13.67 x 800
1y Target Est:21.00
Beta:0.06
Earnings Date:Jul 24 - Jul 25 (Est.)
Day's Range:13.55 - 13.79
52wk Range:8.57 - 20.29
Volume:41,177
Avg Vol (3m):530,583
Market Cap:1.03B
P/E (ttm):N/A
EPS (ttm):-0.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NBIX

Comparison

Symbol% ChgMkt Cap
NBIXDown 1.09%1.03B
ABTDown 0.21%64.40B
LLYDown 0.05%68.89B
PFEUp 0.23%194.30B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):475.14
Ex-Dividend Date:29-Dec-95

Analysts

Annual EPS Est (Dec-14) :-0.79
Quarterly EPS Est (Jun-14) :-0.18
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-1.31

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Neurocrine Biosciences, Inc. discovers, develops, and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback